Blog

DEEP RESEARCH · APR

APR: A Global Beauty-Tech Paradigm Shift

The growth flywheel built by Medicube AGE-R, repeat cosmetics purchases, and in-house R&D/manufacturing

Date: 2026-01-22 · Company analysis · Naver Blog

Investment decisions are your responsibility. This research is not a buy or sell recommendation.

0. Bottom Line First

My core view is that APR is not just a cosmetics company with beauty devices attached. The important structure is that device adoption can drive repeat cosmetics purchases and customer data, which then feeds product development again.

  • APR began with Aprilskin and media commerce in 2014, and the 2021 launch of Medicube AGE-R was the decisive pivot.
  • 2024 revenue was presented as KRW 722.8 billion, operating profit as KRW 122.7 billion, and operating margin as 17.0%.
  • For cumulative 3Q 2025, revenue was presented as KRW 901.5 billion, operating profit as KRW 230.8 billion, and OPM as 25.6%, with annual revenue above KRW 1 trillion discussed as likely.
  • Key risks are FDA and NMPA regulation, low-priced Chinese copycat products, patent disputes, and higher global marketing expenses.

APR business overview image

1. Business Essence: From Cosmetics to a Home-Clinic Platform

Official fact: APR was founded in 2014, launched Medicube AGE-R in March 2021, and listed on KOSPI in February 2024.

Interpretation: Early SNS-based D2C and media-commerce capability was a way to sell products quickly. After AGE-R, that capability expanded into owning the customer routine by combining devices and cosmetics.

APR FlywheelCombining devices and cosmetics
Device adoptionAGE-R, Booster Pro
Dedicated cosmeticsRepeat gel, ampoule, and pad purchases
D2C dataSkin concerns, reviews, purchase patterns
R&D feedbackADC and APR Factory
Durable-goods sales can lead to recurring purchases and new product development.

2. Growth History and Brand Portfolio

PeriodCore changeMeaning
2014-2016Aprilskin, Magic Snow Cushion, SNS media commerceBuilt D2C and content-selling capability
2016-2020Medicube, Nerdy, Forment, Photogray launchesExpanded into a brand house and lifestyle portfolio
2021-presentAGE-R, Booster Pro, Ultra Tune 40.68, High Focus ShotShifted corporate identity toward home beauty devices
Beauty Device

AGE-R

The line brings electroporation, RF, and HIFU concepts into at-home devices such as Booster Pro, Ultra Tune 40.68, and High Focus Shot.

Cosmetics

Medicube

Zero Pore Pad, the PDRN line, and booster gels and creams are linked to device usage.

Other Brands

Aprilskin, Forment, Nerdy

The portfolio expanded into clean beauty, fragrance/body care, and fashion, but the center of gravity is increasingly beauty.

3. Product and Technology Edge

Official fact: Booster Pro is described as offering glow, elasticity, volume, and pore modes in one device. Ultra Tune 40.68 is described as applying 40.68MHz RF. As of 3Q 2025, domestic and overseas patent applications and registrations were presented as exceeding 300.

  • Electroporation is described as a technology that helps active cosmetic ingredients penetrate the skin.
  • RF is framed around deep dermal heat and collagen-generation logic.
  • HIFU is described as focusing ultrasonic energy at a target depth for a lifting effect.
  • The competitive point is not a single function but an all-in-one multi-function device tied to cosmetics.

APR product and financial-performance image

4. Financials and Global Expansion

YearRevenueOperating profitOPM
2020KRW 219.9bnKRW 14.5bn6.6%
2021KRW 259.1bnKRW 14.3bn5.5%
2022KRW 397.7bnKRW 39.2bn9.9%
2023KRW 523.8bnKRW 104.2bn19.9%
2024KRW 722.8bnKRW 122.7bn17.0%
3Q 2025 cumulativeKRW 901.5bnKRW 230.8bn25.6%

Interpretation: A higher beauty-device mix and global D2C expansion lifted margins, but overseas channel expansion also makes marketing expense and inventory control important.

5. Risks and Checkpoints

APR risk and outlook image

  • Tighter U.S. FDA or China NMPA standards could raise approval costs or delay launches.
  • Low-priced Chinese copycats could pressure market pricing, while APR’s response is framed around brand premium, app connectivity, and cosmetics bundles.
  • Patent disputes can become more relevant as APR is revalued as a technology company, making the IP portfolio important.
  • For 2026, I would track U.S. and Japan channel expansion, Europe and Southeast Asia contribution, and the next device launch schedule.

Sources

Naver original